By Professor Peter Ian Croucher

Conference Papers

Croucher P; Khoo WH; Chai R; Corr A; Smith J; Ren Q; Baldock P; McDonald M; Stewart S; Phan TG, 2021, 'Niche-dependent control of tumor cell dormancy', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, ELECTR NETWORK, presented at AACR Virtual Conference on Evolving Tumor Microenvironment in Cancer Progression - Mechanisms and Emerging Therapeutic Opportunities, ELECTR NETWORK, 11 January 2021 - 12 January 2021, http://dx.doi.org/10.1158/1538-7445.TME21-IA015

Opperman K; Vandyke K; Psaltis P; Croucher P; Noll J; Zannettino A, 2019, 'Macrophages as a potential therapeutic target: Clodronate-liposome treatment inhibits multiple myeloma tumour establishment in vivo', in CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, CIG MEDIA GROUP, LP, pp. E96 - E96, http://dx.doi.org/10.1016/j.clml.2019.09.156

Beck-Cormier S; Lelliott CJ; Logan JG; Lafont DT; Merametdjian L; Leitch VD; Butterfield NC; Protheroe HJ; Croucher PI; Baldock PA; Gaultier-Lintia A; Maugars Y; Nicolas G; Banse C; Normant S; Magne N; Gérardin E; Bon N; Sourice S; Guicheux J; Beck L; Williams GR; Bassett JHD, 2019, 'Slc20a2, Encoding the Phosphate Transporter PiT2, Is an Important Genetic Determinant of Bone Quality and Strength', in Journal of Bone and Mineral Research, pp. 1101 - 1114, http://dx.doi.org/10.1002/jbmr.3691

Khor E-C; Fanashawe B; Qi Y; Croucher P; Herzog H; Baldock P, 2014, 'SNORD116, a Non-translated, Imprinted Central Regulator of Bone Mass: Possible Role in Skeletal Abnormalities in Prader-Willi Syndrome.', in JOURNAL OF BONE AND MINERAL RESEARCH, WILEY-BLACKWELL, TX, Houston, pp. S72 - S72, presented at Annual Meeting of the American-Society-for-Bone-and-Mineral-Research, TX, Houston, 12 September 2014 - 15 September 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000356598700214&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Holen I; Wang N; Reeves KJ; Fowles AM; Croucher PI; Eaton CL; Ottewell PD, 2012, 'Abstract PD07-08: Zoledronic acid specifically inhibits development of bone metastases in the post-menopausal setting – evidence from an in vivo breast cancer model', in Cancer Research, American Association for Cancer Research (AACR), http://dx.doi.org/10.1158/0008-5472.sabcs12-pd07-08

Croucher PI; Shipman CM; Van Camp B; Vanderkerken K, 2003, 'Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease', in Cancer, pp. 818 - 824, http://dx.doi.org/10.1002/cncr.11125

Shipman CM; Rogers MJ; Vanderkerken K; Van Camp B; Russell RGG; Croucher PI, 2000, 'Bisphosphonates: Mechanisms of action in multiple myeloma', in Acta Oncologica, pp. 829 - 835, http://dx.doi.org/10.1080/028418600750063587

Russell RGG; Croucher PI; Rogers MJ, 1999, 'Bisphosphonates: Pharmacology, mechanisms of action and clinical uses', in Osteoporosis International, pp. S66 - S80, http://dx.doi.org/10.1007/PL00004164

Croucher PI; Wang F; Hargreaves PG, 1999, 'Interleukin-6 receptor shedding: A possible role for members of the ADAM family', in Biochemical Society Transactions, pp. 224 - 228, http://dx.doi.org/10.1042/bst0270224

Russell RGG; Rogers MJ; Frith JC; Luckman SP; Coxon FP; Benford HL; Croucher PI; Shipman C; Fleisch HA, 1999, 'The pharmacology of bisphosphonates and new insights into their mechanisms of action', in Journal of Bone and Mineral Research, pp. 53 - 65, http://dx.doi.org/10.1002/jbmr.5650140212

Back to profile page